13F Portfolios

MAK CAPITAL ONE LLC: AUTOLUS THERAPEUTICS LTD (AUTL): Quarterly 13F Position History

As of Q2 2026, MAK CAPITAL ONE LLC reported 33,621,487 shares of AUTOLUS THERAPEUTICS LTD (AUTL), worth $53.8M and representing 7.5% of its 13F equity book. The position first appeared in Q2 2025 and has been disclosed across 5 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q2 2026 33,621,487 0 $53.8M 7.5% $1.6
Q1 2026 33,621,487 +3,616,144 +12.1% $46.4M 7.7% $1.4
Q4 2025 30,005,343 +3,987,727 +15.3% $59.7M 8.0% $2.0
Q3 2025 26,017,616 +9,062,518 +53.5% $42.4M 8.5% $1.6
Q2 2025 16,955,098 $38.7M 6.8% $2.3

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.

When did MAK CAPITAL ONE LLC first disclose a AUTL position in 13F-HR filings?

MAK CAPITAL ONE LLC first reported AUTOLUS THERAPEUTICS LTD (AUTL) on its 13F-HR filing for the period ending 2025-06-30 (Q2 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.

What was MAK CAPITAL ONE LLC's most recent quarter-over-quarter share-count change in AUTL?

MAK CAPITAL ONE LLC held the same 33,621,487 shares of AUTL between Q1 2026 and Q2 2026, so the reported share count was unchanged quarter-over-quarter.

Does the implied price-per-share represent MAK CAPITAL ONE LLC's cost basis in AUTL?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.